https://pipelinereview.com/ValenzaBio-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-VB421-an-Anti-IGF-1R-Monoclonal-Antibody-for-the-Treatment-of-Thyroid-Eye-Disease/